MedGenome, backed by Sequoia Capital, LeapFrog Investments, Novo Holdings, Sofina, HDFC, Emerge Ventures, Zodius Capital and International ...

Plans are still on the drawing board and the storied Silicon Valley venture capitalist (VC) may not necessarily follow through with them, t...

This Father’s Day, let's raise a toast to the legacy of Y chromosome since time immemorial.

Recalling the turbulent journey, Dr Yatin Mehta, Chairman of Medanta Institute of Critical Care and Anesthesiology at Medanta - The Medicit...

Being the first to get approvals from regulators to produce test kits tipped the scales in their favour.

A look at the shortlisted startups for the Healthcare Innovation and Midas Touch categories for The Economic Times Startup Awards 2020.

Currently, genomics is widely used in areas such as oncology, infectious diseases (especially tuberculosis), rare diseases, reproductive he...

The size of the industry, which is pegged at Rs 300-400 crore, has been growing at 30% annually.

MedGenome will use the proceeds to expand the clinical genomic testing market by entering Tier-II and Tier-III towns and cities and “democr...

In software, I was hands on. I knew I could do it if something comes up suddenly; I could fix it with a few programmers over the weekend, S...

The round also saw participation from Zodius Capital, former Infosys CEO Kris Gopalakrishnan and former Cognizant CEO Lakshmi Narayanan.

MedGenome has seen the number of samples triple for genetic tests in of samples triple for genetic tests in the last one year.

Sequoia is considering plans to raise about Rs 5,000 cr for a new fund, after it underlined its strategy for an aggressive pace of investme...

“We would use these funds to ensure better collaboration with various research institutions across India,“ chairman and CEO Sam Santhosh sa...